Else Munthe
Overview
Explore the profile of Else Munthe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Namlos H, Skarn M, Ahmed D, Grad I, Andresen K, Kresse S, et al.
BMC Genomics
. 2022 Feb;
23(1):142.
PMID: 35172717
Background: Osteosarcoma is the most common primary malignant tumour of bone occurring in children and young adolescents and is characterised by complex genetic and epigenetic changes. The miRNA miR-486-5p has...
2.
Munthe E, Raiborg C, Stenmark H, Wenzel E
J Cell Sci
. 2020 Jun;
133(13).
PMID: 32546530
The canonical Wnt/β-catenin signaling pathway regulates cell proliferation in development and adult tissue homeostasis. Dysregulated signaling contributes to human diseases, in particular cancer. Growing evidence suggests a role for clathrin...
3.
Hanes R, Munthe E, Grad I, Han J, Karlsen I, McCormack E, et al.
Cells
. 2019 Feb;
8(2).
PMID: 30795553
FGFR inhibition has been proposed as treatment for dedifferentiated liposarcoma (DDLPS) with amplified , but we previously only demonstrated transient cytostatic effects when treating -amplified DDLPS cells with NVP-BGJ398. Effects...
4.
Namlos H, Boye K, Mishkin S, Baroy T, Lorenz S, Bjerkehagen B, et al.
Mol Cancer Ther
. 2018 Aug;
17(11):2473-2480.
PMID: 30097488
Molecular analysis of circulating tumor DNA (ctDNA) has a large potential for clinical application by capturing tumor-specific aberrations through noninvasive sampling. In gastrointestinal stromal tumor (GIST), analysis of and mutations...
5.
Gouravan S, Meza-Zepeda L, Myklebost O, Stratford E, Munthe E
Int J Mol Sci
. 2018 Mar;
19(4).
PMID: 29570692
Methods: Four sarcoma cell lines harboring the BRAFV600E mutation, representing liposarcomas (SA-4 and SW872), Ewing sarcoma (A673) and atypical synovial sarcoma (SW982), were treated with vemurafenib and the effects on...
6.
Serguienko A, Hanes R, Grad I, Wang M, Myklebost O, Munthe E
Stem Cells Dev
. 2017 Aug;
26(19):1375-1383.
PMID: 28805158
Bone marrow mesenchymal stem cells (BM-MSCs) mediate skeletal remodeling by differentiating into osteoblasts. However, this remodeling is impaired with aging as well as following long-term glucocorticoid treatment, resulting in osteoporosis....
7.
Sandhu V, Wedge D, Bowitz Lothe I, Labori K, Dentro S, Buanes T, et al.
Cancer Res
. 2016 Aug;
76(17):5092-102.
PMID: 27488532
Despite advances in diagnostics, less than 5% of patients with periampullary tumors experience an overall survival of five years or more. Periampullary tumors are neoplasms that arise in the vicinity...
8.
Hanes R, Grad I, Lorenz S, Stratford E, Munthe E, Reddy C, et al.
Oncotarget
. 2016 Jul;
7(34):54583-54595.
PMID: 27409346
Sarcomas are rare cancers with limited treatment options. Patients are generally treated by chemotherapy and/or radiotherapy in combination with surgery, and would benefit from new personalized approaches. In this study...
9.
Munthe E, Riss P, Saga T, Haraldsen I, Grad I, Bogsrud T, et al.
Clin Physiol Funct Imaging
. 2016 Jun;
38(1):34-37.
PMID: 27297457
Background: Glucose metabolism can be studied in vitro by a variety of means, also by fluorodeoxyglucose (FDG). As an example of the potential use we have compared the high glucose...
10.
Serguienko A, Grad I, Wennerstrom A, Meza-Zepeda L, Thiede B, Stratford E, et al.
Oncotarget
. 2015 Feb;
6(4):2451-65.
PMID: 25669981
Let-7 microRNAs (miRNAs) are highly conserved well-established promoters of terminal differentiation that are expressed in healthy adult tissues and frequently repressed in cancer cells. The tumor suppressive role of let-7...